Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT05224271
Official study title

Evaluating Patient Reported Outcomes in Radiation Therapy, the PRO-RT Study

Study summary

This study explores the use of the Hugo platform to involve study participants in their healthcare and treatments. The Hugo platform may allow researchers to collect better and more accurate real-time health data, from other clinics/hospitals, pharmacies and other electronic devices. The purpose of this research is to see if the use of the Hugo platform is consistent, accurate, cost effective, and time efficient, as it collects and transmits important real-time health information from other clinics/hospitals, pharmacies, and other electronic devices.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedElectronic Health Record Review and Medical Device Usage and Evaluation

Plus 1 other study approaches.

Who it may be forBreast Carcinoma · Head and Neck Carcinoma

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Sep 19, 2024 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Mayo Clinic

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
Mayo Clinic
Interventions being studied
Other: Electronic Health Record Review; Other: Medical Device Usage and Evaluation; Other: Survey Administration
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
Radiation therapy→
Study topics
Survivorship and quality of life→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Age 18+
  • English speaking
  • Consented for Outcomes Registry Study (15-000136)
  • Undergoing radiotherapy for cancer treatment with curative intent
  • Willing to and able to give consent and participate in study
  • Willing to complete all surveys
  • Able to access a device (computer, smartphone, or tablet) with web access every day to complete study surveys
  • Willing to connect to a device (i.e., a smartphone, Fitbit, or tablet) that can regularly link to Hugo for data transfer
  • Willing to share personal information to Tremendous to be able to obtain the Visa e-cards for time and effort put into this study
  • Willing to use the Hugo health data sharing platform
  • Willing to create a Mayo Clinic Patient Portal (if not already created)
Reasons someone may not be able to joinExclusion criteria
  • Unable to give consent and enroll prior to administration of baseline survey
  • Partial breast radiation therapy (RT) (3 fraction), due to overlap in cadence used for all disease sites
  • Stereotactic body radiation therapy (SBRT) to the lung, due to overlap in cadence used for all disease sites
  • Co-enrollment on another PRO related study (soft rule)
  • Coordinator would need to get source data from Adam via Hugo
  • Response data will only be accessible by select people

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Mayo Clinic in RochesterRochester, Minnesota

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Sep 19, 2024. Always confirm current availability with the study team.

View original record ↗